A phase I trial of bortezomib in combination with epirubicin, carboplatin and capecitabine (ECarboX) in advanced oesophagogastric adenocarcinoma

Author: Turkington R.   Purcell C.   James C.   Millar J.   Napier E.   Law D.   Gallagher R.   Morris M.   Wilson R.   Eatock M.  

Publisher: Springer Publishing Company

ISSN: 0167-6997

Source: Investigational New Drugs, Vol.32, Iss.2, 2014-04, pp. : 250-260

Disclaimer: Any content in publications that violate the sovereignty, the constitution or regulations of the PRC is not accepted or approved by CNPIEC.

Previous Menu Next

Related content